» Articles » PMID: 859443

Papillary Thyroid Carcinoma: the Impact of Therapy in 576 Patients

Overview
Specialty General Medicine
Date 1977 May 1
PMID 859443
Citations 95
Authors
Affiliations
Soon will be listed here.
Citing Articles

Physicians' preferencesfor radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study.

Padovani R, Pansani I, Marone M, Vaisman F, Maia A, Dora J Arch Endocrinol Metab. 2024; 68:e230228.

PMID: 39420903 PMC: 11196101. DOI: 10.20945/2359-4292-2023-0228.


Decision Variables for the Use of Radioactive Iodine in Patients with Thyroid Cancer at Intermediate Risk of Recurrence.

Newman S, Patrizio A, Boucai L Cancers (Basel). 2024; 16(17).

PMID: 39272954 PMC: 11394252. DOI: 10.3390/cancers16173096.


A tribute to Ernest L. Mazzaferri, MD and the lasting impact that he had on thyroid cancer care ten years after his death.

Cooper D, Ringel M Endocrine. 2023; 80(3):500-502.

PMID: 37178311 DOI: 10.1007/s12020-023-03385-9.


Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma.

Minaldi E, Giani C, Agate L, Molinaro E, Elisei R Thyroid Res. 2023; 16(1):2.

PMID: 36642720 PMC: 9841632. DOI: 10.1186/s13044-022-00143-3.


Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma.

Zanella A, Marmitt L, Fighera T, Scheffel R, Spritzer P, Dora J Metabolites. 2022; 12(9).

PMID: 36144246 PMC: 9500704. DOI: 10.3390/metabo12090842.